Comparative Analysis, page-114

Could I suggest we focus our attention and posts on CHM and not other posters..

We all invested to make a return on Invested Capital, the Science is phenomenal and it would seem none of us agree with Managements dilution and being able to take advantage of Buying Opportunities whilst normal SH were locked out...

The only hope seems for CHM to be sold IMHO,,, once faith in Management is lost in these Biotechs its hardly ever corrected..

Again its a real pity we didn't have Rebecca earlier kudos to her for cementing $4m in non dilutive funding... NZT